Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older (male or female)
- You have been diagnosed with LAM (lymphangioleiomyomatosis) based on recognised medical guidelines
- You are willing and able to sign and date a consent form agreeing to take part
- You are currently taking, newly starting, or being considered for mTOR inhibitor medication, or you have previously tried mTOR inhibitors but could not tolerate them or they did not work for you
Who may not be able to join:
- You are unable to attend the specialist clinic at least once a year
- You are unable to give your own informed consent to take part in the trial
- You are unable or unwilling to take breathing/lung function tests
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francis X McCormack, MD, University of Cincinnati
Phone: (513) 558-4376
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Long term safety of mTOR inhibitor treatment in LAM; Efficacy - FEV1 slope; Efficacy -10% reduction in FEV1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.